Desktop Site
|
19 Apr 24 | 13:48
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
72,760.81
+271.82
+0.37 %
Corporate Announcement
Security Code
524558
Company
NEULAND LABORATORIES LTD.
Exchange Received Time
22/05/2020 15:25:03
Exchange Disseminated Time
22/05/2020 15:25:12
Time Taken
00:00:09
Outcome Of Board Meeting |
5/22/2020 3:25:05 PM
Please find enclosed the Audited Financial Results (Standalone & Consolidated) of the Company for the year ended March 31, 2020 under Ind AS, which have been approved and taken on record at a meeting of the Board of Directors of the Company held on even date.
We would like to state that M/s. MSKA & Associates, Chartered Accountants (FRN: 105047W), Statutory Auditors of the Company, have issued audit reports with unmodified opinion on the aforementioned Audited Financial Results (enclosed).
Further, the Board has approved the re-appointment of Mr. Davuluri Saharsh Rao, as a Whole-Time Director, designated as Joint Managing Director of the Company, for a period of five years with effect from June 1, 2020, subject to the approval of the shareholders at the ensuing Annual General Meeting.
The meeting of the Board of Directors of the Company commenced at 11.30 A.M. and concluded at 03:00 P.M.
This is for your information and records.
Attachment
<< Back
Recently Viewed